Jonathan Keats

32PUBLICATIONS
256CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersHaematological tumoursGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Dec 09, 2025
Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma.

Denis J Ohlstrom, William C Pilcher, Marina E Michaud

|Jun 09, 2025
Author Correction: Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes.

Sheri Skerget, Daniel Penaherrera, Ajai Chari

|Jun 09, 2025
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma.

Hervé Avet-Loiseau, Faith E Davies, Mehmet K Samur

|Oct 14, 2024
Functional variant rs9344 at 11q13.3 regulates CCND1 expression in multiple myeloma with t(11;14).

Hongwei Tang, Huihuang Yan, Suganti Shivaram

|Aug 19, 2024
Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes.

Sheri Skerget, Daniel Penaherrera, Ajai Chari

|Nov 29, 2023
Clinical Outcomes and Evolution of Clonal Hematopoiesis in Patients with Newly Diagnosed Multiple Myeloma.

Tarek H Mouhieddine, Chidimma Nzerem, Robert Redd

Pageof 6

Frequent Collaborators

6 joint publications

Shaji Kumar

6 joint publications

P Leif Bergsagel

6 joint publications

Brian A Walker

6 joint publications

Francesco Maura